Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis

被引:4511
作者
El-Serag, Hashem B. [1 ]
Rudolph, Lenhard
机构
[1] Michael E DeBakey Vet Adm Med Ctr, Houston, TX USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Ctr Qual Care & Utilizat Studies, Houston, TX USA
[4] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany
关键词
D O I
10.1053/j.gastro.2007.04.061
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Primary liver cancer, which consists predominantly of hepatocellular carcinoma (HCC), is the fifth most common cancer worldwide and the third most common cause of cancer mortality. HCC has several interesting epidemiologic features including dynamic temporal trends; marked variations among geographic regions, racial and ethnic groups, and between men and women; and the presence of several well-documented environmental potentially preventable risk factors. Moreover, there is a growing understanding on the molecular mechanisms inducing hepatocarcinogenesis, which almost never occurs in healthy liver, but the cancer risk increases sharply in response to chronic liver injury at the cirrhosis stage. A detailed understanding of epidemiologic factors and molecular mechanisms associated with HCC ultimately could improve our current concepts for screening and treatment of this disease.
引用
收藏
页码:2557 / 2576
页数:20
相关论文
共 184 条
  • [11] Liver fibrosis
    Bataller, R
    Brenner, DA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) : 209 - 218
  • [12] BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO
  • [13] 2-J
  • [14] Impaired DNA replication within progenitor cell pools promotes leukemogenesis
    Bilousova, G
    Marusyk, A
    Porter, CC
    Cardiff, RD
    DeGregori, J
    [J]. PLOS BIOLOGY, 2005, 3 (12) : 2135 - 2147
  • [15] Increased incidence of HFE C282Y mutations in patients, with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver
    Blanc, JF
    De Ledinghen, V
    Bernard, PH
    de Verneuil, H
    Winnock, M
    Le Bail, B
    Carles, J
    Saric, J
    Balabaud, C
    Bioulac-Sage, P
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 (05) : 805 - 811
  • [16] Meta-analysis of studies of occupational exposure to vinyl chloride in relation to cancer mortality
    Boffetta, P
    Matisane, L
    Mundt, KA
    Dell, LD
    [J]. SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 2003, 29 (03) : 220 - 229
  • [17] Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis
    Boige, V
    Castéra, L
    de Roux, N
    Ganne-Carrié, N
    Ducot, B
    Pelletier, G
    Beaugrand, M
    Buffet, C
    [J]. GUT, 2003, 52 (08) : 1178 - 1181
  • [18] SELECTIVE G-MUTATION TO T-MUTATION OF P53 GENE IN HEPATOCELLULAR-CARCINOMA FROM SOUTHERN AFRICA
    BRESSAC, B
    KEW, M
    WANDS, J
    OZTURK, M
    [J]. NATURE, 1991, 350 (6317) : 429 - 431
  • [19] Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression
    Breuhahn, K
    Vreden, S
    Haddad, R
    Beckebaum, S
    Stippel, D
    Flemming, P
    Nussbaum, T
    Caselmann, WH
    Haab, BB
    Schirmacher, P
    [J]. CANCER RESEARCH, 2004, 64 (17) : 6058 - 6064
  • [20] Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C
    Bruno, S
    Battezzati, PM
    Bellati, G
    Manzin, A
    Maggioni, M
    Crosignani, A
    Borzio, M
    Solforosi, L
    Morabito, A
    Ideo, G
    Podda, M
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 (05) : 748 - 755